17.34
price up icon8.71%   1.39
after-market 시간 외 거래: 17.14 -0.20 -1.15%
loading
전일 마감가:
$15.95
열려 있는:
$15.26
하루 거래량:
67,982
Relative Volume:
0.79
시가총액:
$149.75M
수익:
-
순이익/손실:
$-81.17M
주가수익비율:
-1.711
EPS:
-10.1344
순현금흐름:
$-82.84M
1주 성능:
-2.36%
1개월 성능:
-30.83%
6개월 성능:
-47.42%
1년 성능:
-79.02%
1일 변동 폭
Value
$15.21
$18.28
1주일 범위
Value
$15.16
$18.77
52주 변동 폭
Value
$15.16
$98.00

Korro Bio Inc Stock (KRRO) Company Profile

Name
명칭
Korro Bio Inc
Name
전화
617-468-1999
Name
주소
60 FIRST STREET, CAMBRIDGE
Name
직원
104
Name
트위터
Name
다음 수익 날짜
2024-12-08
Name
최신 SEC 제출 서류
Name
KRRO's Discussions on Twitter

KRRO을(를) 다른 주식과 비교

주식 가격 시가총액 매출 순이익 현금흐름 주당 순 이익
Biotechnology icon
KRRO
Korro Bio Inc
17.34 149.75M 0 -81.17M -82.84M -10.13
Biotechnology icon
VRTX
Vertex Pharmaceuticals Inc
483.49 124.48B 11.02B -535.60M -978.00M -2.20
Biotechnology icon
REGN
Regeneron Pharmaceuticals Inc
625.60 67.45B 14.20B 4.41B 3.54B 38.28
Biotechnology icon
ARGX
Argen X Se Adr
583.62 35.60B 2.19B 833.04M -1.28B 12.71
Biotechnology icon
ALNY
Alnylam Pharmaceuticals Inc
266.83 34.53B 2.25B -278.16M -42.59M -2.17
Biotechnology icon
ONC
Beigene Ltd Adr
274.78 29.15B 3.81B -644.79M -669.77M -6.24

Korro Bio Inc Stock (KRRO) Upgrades & Downgrades

날짜 액션 분석자 등급 변경
2025-01-10 개시 Oppenheimer Outperform
2024-10-21 개시 Raymond James Strong Buy
2024-08-14 개시 William Blair Outperform
2024-03-28 재확인 H.C. Wainwright Buy
2024-02-27 개시 BMO Capital Markets Outperform
2023-12-04 개시 H.C. Wainwright Buy
2023-11-29 개시 RBC Capital Mkts Outperform
2023-11-10 개시 Piper Sandler Overweight
2023-02-15 다운그레이드 Chardan Capital Markets Buy → Neutral
2023-02-13 다운그레이드 Cowen Outperform → Market Perform
2021-09-22 다운그레이드 Goldman Buy → Neutral
2021-01-27 업그레이드 JP Morgan Neutral → Overweight
2020-12-22 개시 B. Riley Securities Buy
2020-07-14 개시 Oppenheimer Outperform
2020-05-18 다운그레이드 JP Morgan Overweight → Neutral
2019-10-28 개시 Cowen Outperform
2019-10-28 개시 Goldman Buy
2019-10-28 개시 JP Morgan Overweight
모두보기

Korro Bio Inc 주식(KRRO)의 최신 뉴스

pulisher
Apr 01, 2025

Korro Bio appoints new Chief Scientific Officer By Investing.com - Investing.com South Africa

Apr 01, 2025
pulisher
Apr 01, 2025

Korro Bio appoints new Chief Scientific Officer - Investing.com

Apr 01, 2025
pulisher
Apr 01, 2025

Korro Appoints Biotech Industry Veteran, Loïc Vincent, Ph.D., as Chief Scientific Officer - Yahoo Finance

Apr 01, 2025
pulisher
Mar 28, 2025

Korro Bio: Promising Early Stage RNA Editing Company (NASDAQ:KRRO) - Seeking Alpha

Mar 28, 2025
pulisher
Mar 28, 2025

Korro Bio reappoints CFO, names new principal accounting officer By Investing.com - Investing.com Canada

Mar 28, 2025
pulisher
Mar 27, 2025

Korro Bio CFO Returns from Medical Leave - TipRanks

Mar 27, 2025
pulisher
Mar 27, 2025

Korro Bio reappoints CFO, names new principal accounting officer - Investing.com

Mar 27, 2025
pulisher
Mar 27, 2025

Korro Bio Inc Vineet Agarwal Ends Temporary Medical Leave As CFO - MarketScreener

Mar 27, 2025
pulisher
Mar 24, 2025

Research Analysts Set Expectations for Korro Bio Q1 Earnings - Defense World

Mar 24, 2025
pulisher
Mar 23, 2025

Q1 Earnings Forecast for Korro Bio Issued By William Blair - Armenian Reporter

Mar 23, 2025
pulisher
Mar 22, 2025

HC Wainwright Reiterates Buy Rating for Korro Bio (NASDAQ:KRRO) - Defense World

Mar 22, 2025
pulisher
Mar 22, 2025

Q1 Earnings Estimate for Korro Bio Issued By William Blair - Defense World

Mar 22, 2025
pulisher
Mar 21, 2025

Royal Bank of Canada Has Lowered Expectations for Korro Bio (NASDAQ:KRRO) Stock Price - Defense World

Mar 21, 2025
pulisher
Mar 21, 2025

Korro Bio Reports 2024 Financial Results and Progress - TipRanks

Mar 21, 2025
pulisher
Mar 20, 2025

H.C. Wainwright maintains Buy rating on Korro Bio stock By Investing.com - Investing.com Australia

Mar 20, 2025
pulisher
Mar 20, 2025

H.C. Wainwright maintains Buy rating on Korro Bio stock - Investing.com

Mar 20, 2025
pulisher
Mar 20, 2025

Korro Bio, Inc. (NASDAQ:KRRO) Given Consensus Recommendation of “Buy” by Analysts - Defense World

Mar 20, 2025
pulisher
Mar 19, 2025

Korro Bio’s SWOT analysis: RNA editing firm’s stock poised for growth - Investing.com Australia

Mar 19, 2025
pulisher
Mar 19, 2025

Korro Bio’s SWOT analysis: RNA editing firm’s stock poised for growth By Investing.com - Investing.com South Africa

Mar 19, 2025
pulisher
Mar 19, 2025

Is Korro Bio (NASDAQ:KRRO) In A Good Position To Invest In Growth? - Yahoo Finance

Mar 19, 2025
pulisher
Mar 19, 2025

RBC Cuts Price Target on Korro Bio to $95 From $105, Keeps Outperform, Speculative Risk - Marketscreener.com

Mar 19, 2025
pulisher
Mar 19, 2025

Korro Bio’s Promising Growth: Buy Rating Backed by Positive KRRO-110 Trial Progress and Market Opportunities - TipRanks

Mar 19, 2025
pulisher
Mar 18, 2025

Korro Bio, Inc. SEC 10-K Report - TradingView

Mar 18, 2025
pulisher
Mar 18, 2025

Korro Reports Full Year 2024 Financial Results and Provides Business Updates - The Manila Times

Mar 18, 2025
pulisher
Mar 18, 2025

Korro Bio Reports Clean Safety Data in AATD Drug Trial, Secures $163M Runway - StockTitan

Mar 18, 2025
pulisher
Mar 18, 2025

Korro Bio (KRRO) Projected to Post Earnings on Tuesday - Defense World

Mar 18, 2025
pulisher
Mar 15, 2025

FDA grants orphan drug status to Korro’s AATD treatment By Investing.com - Investing.com Australia

Mar 15, 2025
pulisher
Mar 14, 2025

Korro Bio gets FDA Orphan Drug tag (KRRO:NASDAQ) - Seeking Alpha

Mar 14, 2025
pulisher
Mar 14, 2025

Korro Bio's Potential Antitrypsin Deficiency Treatment Receives US FDA Orphan Drug Designation - Marketscreener.com

Mar 14, 2025
pulisher
Mar 14, 2025

FDA grants orphan drug status to Korro’s AATD treatment - Investing.com

Mar 14, 2025
pulisher
Mar 14, 2025

KRRO-110 Receives Orphan Drug Designation from U.S. FDA for Alpha-1 Antitrypsin Deficiency - The Manila Times

Mar 14, 2025
pulisher
Mar 14, 2025

Breakthrough for Rare Disease: FDA Awards Special Status to Korro Bio's Novel RNA Treatment - StockTitan

Mar 14, 2025
pulisher
Mar 10, 2025

Rhumbline Advisers Purchases 691 Shares of Korro Bio, Inc. (NASDAQ:KRRO) - Defense World

Mar 10, 2025
pulisher
Feb 26, 2025

Korro to Present at the TD Cowen 45th Annual Health Care Conference - The Manila Times

Feb 26, 2025
pulisher
Feb 26, 2025

What Will Korro Bio Reveal at the TD Cowen Healthcare Conference Next Week? - StockTitan

Feb 26, 2025
pulisher
Feb 23, 2025

Korro Bio, Inc. (NASDAQ:KRRO) Receives Average Rating of “Buy” from Analysts - Defense World

Feb 23, 2025
pulisher
Feb 20, 2025

KRRO stock touches 52-week low at $28.71 amid market challenges - Investing.com Nigeria

Feb 20, 2025
pulisher
Feb 13, 2025

Korro Bio CFO takes medical leave, interim officers appointed - MSN

Feb 13, 2025
pulisher
Feb 11, 2025

Korro Bio CFO takes medical leave, interim officers appointed By Investing.com - Investing.com Nigeria

Feb 11, 2025
pulisher
Feb 11, 2025

Korro Bio Appoints Interim CFO Amid Medical Leave - TipRanks

Feb 11, 2025
pulisher
Feb 11, 2025

Korro Bio, Inc. Appoints Oliver Dolan as Interim Principal Accounting Officer -February 11, 2025 at 04:05 pm EST - Marketscreener.com

Feb 11, 2025
pulisher
Feb 11, 2025

KRRO stock touches 52-week low at $29.8 amid yearly slump - Investing.com

Feb 11, 2025
pulisher
Feb 05, 2025

AllianceBernstein L.P.'s Strategic Acquisition of Korro Bio Inc Shares - GuruFocus.com

Feb 05, 2025
pulisher
Feb 01, 2025

Korro Bio, Inc. (NASDAQ:KRRO) Receives Average Recommendation of "Buy" from Brokerages - MarketBeat

Feb 01, 2025
pulisher
Jan 30, 2025

JPMorgan Chase & Co. Boosts Stock Holdings in Korro Bio, Inc. (NASDAQ:KRRO) - MarketBeat

Jan 30, 2025
pulisher
Jan 30, 2025

Korro Bio, Inc. (NASDAQ:KRRO) Shares Bought by JPMorgan Chase & Co. - Defense World

Jan 30, 2025
pulisher
Jan 29, 2025

Korro Bio, Inc. (NASDAQ:KRRO) Receives Consensus Rating of “Buy” from Analysts - Defense World

Jan 29, 2025
pulisher
Jan 20, 2025

Korro Bio (NASDAQ:KRRO) Doses First Participants in REWRITE Phase 1/2a Clinical Study – Pipeline Update ProvidedOn January 13, 2025, Korro Bio, Inc. issued a press release stating that it had initiated dosing the first participants in its REWRITE Pha - Defense World

Jan 20, 2025
pulisher
Jan 18, 2025

Korro Bio, Inc. (NASDAQ:KRRO) Short Interest Update - MarketBeat

Jan 18, 2025
pulisher
Jan 13, 2025

Korro Bio Announces Dosing of First Participants in REWRITE Phase 1/2a Study of KRRO-110 for Alpha-1 Antitrypsin Deficiency - Marketscreener.com

Jan 13, 2025
pulisher
Jan 13, 2025

Korro Bio Announces Dosing of First Participants in REWRITE Phase 1/2a Study of KRRO-110 for Alpha-1 Antitrypsin Deficiency and Provides Pipeline Update - The Manila Times

Jan 13, 2025

Korro Bio Inc (KRRO) 재무 분석

매출

loading

순이익

loading

현금흐름

loading

주당 순 이익

loading
$73.44
price up icon 2.00%
$68.32
price up icon 0.56%
$31.28
price up icon 0.35%
$20.46
price up icon 8.83%
$93.32
price up icon 3.36%
biotechnology ONC
$274.78
price up icon 1.38%
자본화:     |  볼륨(24시간):